You're reading the free version. Trader adds the live tape and alerts.
Start tracking
EDIT Sale Disclosure
O'neill Gilmore Neil · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$15.56K
O'neill Gilmore Neil CEO
EDIT
Editas Medicine
EDIT
Transaction date
Sep 3, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 1 day later
EDIT daily price context
Close on/before transaction
$3.08
Sep 3, 2026
First close after public filing
$3.03
Sep 8, 2026
30-day return after filing
-7.92%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,124 shares @ $3.04
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001742084-26-000003
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$15.56K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Editas Medicine, Inc. EDIT Current | Sale | Sep 3, 2026 | $15.56K |